Mesa Laboratories (MLAB) FCF Margin (2010 - 2025)

Mesa Laboratories has disclosed FCF Margin across 16 years of filings, most recently posting 27.67% for Q4 2025.

• FCF Margin for Q4 2025 came in at 27.67%, up 12.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 15.33% (down 276.0% YoY), and the FY2025 annual result was 17.66%, down 157.0% from the prior year.
• FCF Margin came in at 27.67% for Q4 2025 at Mesa Laboratories, up from 11.74% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 32.88% in Q1 2021 to a low of 6.02% in Q2 2022.
• The 5-year median for FCF Margin is 18.14% (2023), against an average of 16.81%.
• Across the five-year window, FCF Margin tumbled 3161 bps in 2022 and soared 2511 bps in 2023, its largest moves.
• Mesa Laboratories' FCF Margin stood at 25.3% in 2021, then sank by 56 bps to 11.17% in 2022, then jumped by 74 bps to 19.46% in 2023, then jumped by 42 bps to 27.56% in 2024, then grew by 0 bps to 27.67% in 2025.
• The last three FCF Margin figures came in at 27.67% (Q4 2025), 11.74% (Q3 2025), and 1.48% (Q2 2025), per Business Quant data.